Literature DB >> 15025915

P-chirality-dependent immune activation by phosphorothioate CpG oligodeoxynucleotides.

Arthur M Krieg1, Piotr Guga, Wojciech Stec.   

Abstract

Many of the biologic activities of phosphorothioate oligodeoxynucleotides (PS-oligos) are affected by the sense of chirality of the phosphorus atoms of the internucleotide linkages. Some of the activities are increased by the Rp stereoisomer, and others are increased by the Sp stereoisomer. In previous studies, we showed that PS-oligos containing unmethylated CpG dinucleotides in particular sequence contexts can stimulate B cells and other immune cells. These CpG PS-oligos trigger mitogenactivated protein kinase (MAPK) signaling pathways, causing the induction of B cell proliferation and cytokine and immunoglobulin secretion. We investigated whether the immune stimulation by CpG PS-oligos depends on the sense of their P-chirality. CpG PS-oligos synthesized with internucleotide phosphorothioates of Rp configuration at P-atom showed much stronger MAPK activation and induction of I kappa B degradation after 40 minutes of stimulation compared with PS-oligos synthesized with Sp linkages. In order to determine if the enhanced stimulatory effects of the Rp stereoisomer may result from differential cellular uptake, we examined the rates at which fluorescently labeled Rp or Sp CpG PS-oligos were taken up by B cells, but these were found to be identical to each other and to stereorandom PS-oligos. The stronger stimulatory effect of the R stereoisomer did not last for 48 hours, and (3)H-thymidine incorporation assays at this point showed that only the S stereoisomer was active--to approximately the same level as induced by PS-oligos with stereorandom phosphorothioate linkages. This loss of activity of the R stereoisomer most likely resulted from rapid degradation of the oligonucleotides rather than from reduced interaction with the CpG receptor because PS-oligos in which only the CpG dinucleotide was stereodefined were most stimulatory when the CpG was Rp but not when the CpG was Sp. These studies demonstrate that the sense of Pchirality of PS-oligos plays a major role in determining the biologic activities of CpG motifs. Rp-chirality at the CpG is preferred for best stimulation at early time points, but Sp-chirality of the PS-oligo appears to improve stability and may provide more durable effects in prolonged tissue culture systems.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15025915     DOI: 10.1089/154545703322860807

Source DB:  PubMed          Journal:  Oligonucleotides        ISSN: 1545-4576


  11 in total

1.  Control of phosphorothioate stereochemistry substantially increases the efficacy of antisense oligonucleotides.

Authors:  Naoki Iwamoto; David C D Butler; Nenad Svrzikapa; Susovan Mohapatra; Ivan Zlatev; Dinah W Y Sah; Stephany M Standley; Genliang Lu; Luciano H Apponi; Maria Frank-Kamenetsky; Jason Jingxin Zhang; Chandra Vargeese; Gregory L Verdine
Journal:  Nat Biotechnol       Date:  2017-08-21       Impact factor: 54.908

2.  P-stereocontrolled synthesis of oligo(nucleoside N3'→O5' phosphoramidothioate)s - opportunities and limitations.

Authors:  Ewa Radzikowska; Renata Kaczmarek; Dariusz Korczyński; Agnieszka Krakowiak; Barbara Mikołajczyk; Janina Baraniak; Piotr Guga; Kraig A Wheeler; Tomasz Pawlak; Barbara Nawrot
Journal:  RSC Adv       Date:  2020-09-23       Impact factor: 4.036

3.  Stereochemical bias introduced during RNA synthesis modulates the activity of phosphorothioate siRNAs.

Authors:  Hartmut Jahns; Martina Roos; Jochen Imig; Fabienne Baumann; Yuluan Wang; Ryan Gilmour; Jonathan Hall
Journal:  Nat Commun       Date:  2015-03-06       Impact factor: 14.919

4.  Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators.

Authors:  Ulrike Flierl; Tracy L Nero; Bock Lim; Jane F Arthur; Yu Yao; Stephanie M Jung; Eelo Gitz; Alice Y Pollitt; Maria T K Zaldivia; Martine Jandrot-Perrus; Andreas Schäfer; Bernhard Nieswandt; Robert K Andrews; Michael W Parker; Elizabeth E Gardiner; Karlheinz Peter
Journal:  J Exp Med       Date:  2015-02-02       Impact factor: 14.307

5.  Therapeutic antisense oligonucleotides against cancer: hurdling to the clinic.

Authors:  Pedro M D Moreno; Ana P Pêgo
Journal:  Front Chem       Date:  2014-10-14       Impact factor: 5.221

6.  Electronic Structures of LNA Phosphorothioate Oligonucleotides.

Authors:  Henrik G Bohr; Irene Shim; Cy Stein; Henrik Ørum; Henrik F Hansen; Troels Koch
Journal:  Mol Ther Nucleic Acids       Date:  2017-06-01       Impact factor: 8.886

7.  Phosphodiester backbone of the CpG motif within immunostimulatory oligodeoxynucleotides augments activation of Toll-like receptor 9.

Authors:  Jelka Pohar; Duško Lainšček; Ana Kunšek; Miša-Mojca Cajnko; Roman Jerala; Mojca Benčina
Journal:  Sci Rep       Date:  2017-11-06       Impact factor: 4.379

8.  Characterization of Escherichia coli RNase H Discrimination of DNA Phosphorothioate Stereoisomers.

Authors:  Łukasz J Kiełpiński; Erik Daa Funder; Steffen Schmidt; Peter H Hagedorn
Journal:  Nucleic Acid Ther       Date:  2021-10-07       Impact factor: 5.486

9.  P-Stereodefined phosphorothioate analogs of glycol nucleic acids-synthesis and structural properties.

Authors:  Agnieszka Tomaszewska-Antczak; Katarzyna Jastrzębska; Anna Maciaszek; Barbara Mikołajczyk; Piotr Guga
Journal:  RSC Adv       Date:  2018-07-11       Impact factor: 3.361

10.  Chirality matters: stereo-defined phosphorothioate linkages at the termini of small interfering RNAs improve pharmacology in vivo.

Authors:  Hartmut Jahns; Nate Taneja; Jennifer L S Willoughby; Masaaki Akabane-Nakata; Christopher R Brown; Tuyen Nguyen; Anna Bisbe; Shigeo Matsuda; Matt Hettinger; Rajar M Manoharan; Kallanthottathil G Rajeev; Martin A Maier; Ivan Zlatev; Klaus Charisse; Martin Egli; Muthiah Manoharan
Journal:  Nucleic Acids Res       Date:  2022-02-22       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.